caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1760584007

Scott ChaseD.O.

Family PracticeWindham, MEI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Scott Chase's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
PICKUS, OWEN221580
Nordx
Clinical Laboratory · Scarborough, ME
41145
Michael Wood
Physician Assistant · Standish, ME
1843
Howard Glass
Cardiology · Westbrook, ME
1638
MAINEHEALTH CARE AT HOME1538
Vna Home Health & Hospice
Mass Immunizer Roster Biller · South Portland, ME
1451
MAINEHEALTH1120
Elizabeth Pietras
Diagnostic Radiology · Portland, ME
1122
Peter Ocampo
Podiatry · Scarborough, ME
1127
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
424
Unique beneficiaries
—
Total services
626
Distinct HCPCS
6
Medicare payment
$34K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 548 Family Practice providers in ME — top quintile (cohort median 287).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
11,287
Beneficiaries
—
Total drug cost
$906K
Distinct drugs
175
Brand share
23.5%
Top prescribed drugs
Levothyroxine Sodium380 claims
Omeprazole362 claims
Atorvastatin Calcium331 claims
Amlodipine Besylate287 claims
Hydrocodone/Acetaminophen263 claims
QUALITY · MIPS · 2024
Final MIPS score
97.9
Quality
83.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.97%
APM Entity